Cardiology
From the Journals
AHA flags differing CVD risk in Asian American subgroups
Together, T2D and ASCVD are the leading causes of illness and death among Asian American adults, but there is significant variability in...
Conference Coverage
Napping and AFib risk: The long and the short of it
Both long and short daily naps were linked to atrial fibrillation risk, but in different ways.
Conference Coverage
Cardiovascular disease deaths rise on and after high-pollution days
High levels of air pollution were linked to higher risk of death from MI and stroke in a Polish population.
From the Journals
NSAID use in diabetes may worsen risk for first HF hospitalization
“Given the well-established relationship between the use of NSAIDs and increased HF, these findings are not unexpected because type 2 diabetes is...
Opinion
Is it time to stop treating high triglycerides?
There may be noncardiovascular reasons to treat hypertriglyceridemia.
Feature
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
Opinion
What’s the ‘secret sauce’ to help patients move more?
When surveyed about aerobic exercise and strength training, only 24.6% meet weekly recommendations.
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.